[273] Moreover, low expression of METTL14 correlates with poor prognosis in many other cancer cells such as adenocarcinoma, prostate cancer, breast cancer, gastric cancer, osteosarcoma etc. (Fig. 5). This evidence concerns the gene METTL14 and breast cancer.